results of a trial comparing cabozantinib and sunitinib in mrcc
Published 7 years ago • 106 plays • Length 2:12Download video MP4
Download video MP3
Similar videos
-
3:21
cabosun trial: cabozantinib vs sunitinib for renal cell carcinoma
-
1:44
dr. choueiri on cabosun trial results in rcc
-
2:34
nivo cabozantinib vs sunitinib for first-line treatment of arcc
-
5:26
mrcc: impact of cabosun and checkmate-214
-
2:02
cabozantinib in mrcc
-
6:26
esmo 2016: press brief on results of cabosun trial cabozantinib compared to sunitinib in rcc
-
5:49
cabozantinib improves advanced kidney cancer survival: meteor trial results
-
2:09
comparing afami-cel with existing treatments in synovial sarcoma
-
3:10
keynote-426 rationale and results: pembro plus axitinib vs. sunitinib in mrcc
-
7:08
final analysis of the atlantis cabozantinib comparison
-
1:45
dr. choueiri on cabosun trial results for rcc
-
1:34
dr. tannir discusses sunitinib in combination with temsirolimus for mrcc
-
6:30
the rationale for using cabozantinib
-
59:55
renal cell carcinoma: past, present, and future
-
1:20
dr. choueiri on overall findings of cabosun trial for rcc
-
1:35
checkmate-9er shows efficacy of nivolumab/cabozantinib combo in rcc
-
2:12
cabozantinib improves pfs in metastatic renal cell carcinoma
-
1:12
cabozantinib for advanced renal cell carcinoma: the meteor and cabosun trials
-
2:40
updates on the cabopre phase ii trial in patients with metastatic renal cell carcinoma